These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 339448)

  • 1. A study of two twice-weekly and a once-weekly continuation regimen of tuberculosis chemotherapy, including a comparison of two durations of treatment. 2. Second report: the results at 36 months.
    Tubercle; 1977 Sep; 58(3):129-36. PubMed ID: 339448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of two twice-weekly and once-weekly continuation regimen of tuberculosis chemotherapy, including a comparison of two durations of treatment. 1. First report: the results at 18 months.
    Tubercle; 1976 Dec; 57(4):235-49. PubMed ID: 797075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of daily and twice-weekly continuation regimens of tuberculosis chemotherapy, including a comparison of two durations of sanatorium treatment. 2. Second report: the results from 12 to 24 months.
    Who Collaborating Centre For Tuberculosis Chemotherapy
    Bull World Health Organ; 1973; 48(2):155-65. PubMed ID: 4578361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of daily and twice-weekly continuation regimens of tuberculosis chemotherapy, including a comparison of two durations of sanatorium treatment. 1. First report: the results at 12 months.
    WHO Collaborating Centre for Tuberculosis Chemotherapy
    Bull World Health Organ; 1971; 45(5):573-93. PubMed ID: 4947492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of daily and twice-weekly continuation regimens of tuberculosis chemotherapy, including a comparison of two durations of sanatorium treatment.
    Tubercle; 1976 Mar; 57(1):45-8. PubMed ID: 781965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled comparison of a twice-weekly and three once-weekly regimens in the initial treatment of pulmonary tuberculosis.
    Tuberculosis Chemotherapy Centre
    Bull World Health Organ; 1970; 43(1):143-206. PubMed ID: 5312317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled comparison of oral twice-weekly and oral daily isoniazid plus PAS in newly diagnosed pulmonary tuberculosis.
    Br Med J; 1973 Apr; 2(5857):7-11. PubMed ID: 4633061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-year follow-up of patients with quiescent pulmonary tuberculosis following a year of chemotherapy with an intermittent (twice-weekly) regimen of isoniazid plus streptomycin or a daily regimen of isoniazid plus PAS.
    Nazareth O; Devadatta S; Evans C; Fox W; Janardhanam B; Menon NK; Radhakrishna S; Ramakrishnan CV; Stott H; Tripathy SP; Velu S
    Tubercle; 1966 Jun; 47(2):178-89. PubMed ID: 5963586
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison between SM daily and twice weekly treatment in the regimen of SM, INH and PAS--particularly considering the degree of drug resistance (Report 2) (author's transl)].
    Baba H; Azuma Y
    Kekkaku; 1977 Dec; 52(12):619-26. PubMed ID: 604603
    [No Abstract]   [Full Text] [Related]  

  • 10. Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis. Second report. Third East African/British Medical Research Council Study.
    Tubercle; 1980 Jun; 61(2):59-69. PubMed ID: 6159711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore.
    Lancet; 1975 Dec; 2(7945):1105-9. PubMed ID: 53598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A four-year follow-up of patients with quiescent pulmonary tuberculosis at the end of a year of chemotherapy with twice-weekly isoniazid plus streptomycin or daily isoniazid plus pas.
    Ramakrishnan CV; Devadatta S; Evans C; Fox W; Menon NK; Nazareth O; Radhakrishna S; Sambamoorthy S; Stott H; Tripathy SP; Velu S
    Tubercle; 1969 Jun; 50(2):115-24. PubMed ID: 4892322
    [No Abstract]   [Full Text] [Related]  

  • 13. Study of adverse reactions to a once-weekly regimen of streptomycin plus a slow-release preparation of isoniazid in high dosage for six months.
    Santha T; Fox W; Nazareth O; Prabhakar R; Radhakrishna S; Ramakrishnan CV; Sivasubramanian S; Somasundaram PR; Tripathy SP
    Tubercle; 1976 Jun; 57(2):123-30. PubMed ID: 822548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACONCURRENT COMPARISON OF INTERMITTENT (TWICE-WEEKLY) ISONIAZID PLUS STREPTOMYCIN AND DAILY ISONIAZID PLUS PAS IN THE DOMICILIARY TREATMENT OF PULMONARY TUBERCULOSIS; TUBERCULOSIS CHEMOTHERAPY CENTRE, MADRAS.
    LOTTE A; HATTON F; PERDRIZET S; ROUILLON A
    Bull World Health Organ; 1964; 31(2):247-71. PubMed ID: 14253243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled trial of 6- and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong.
    Tubercle; 1975 Jun; 56(2):81-96. PubMed ID: 1103400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison between SM daily and twice weekly treatment in the regimen of SM, INH and PAS--particularly considering the degree of drug resistance-- (report 1) (author's transl)].
    Baba H; Azuma Y
    Kekkaku; 1975 Jul; 50(7):191-7. PubMed ID: 810615
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlled trial of 6-month and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong. The results up to 30 months.
    Am Rev Respir Dis; 1977 May; 115(5):727-35. PubMed ID: 857713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
    Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
    Snider DE; Zierski M; Graczyk J; Bek E; Farer LS
    Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethambutol plus isoniazid for the treatment of pulmonary tuberculosis--a controlled trial of our regimens.
    Tubercle; 1981 Mar; 62(1):13-29. PubMed ID: 7022973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.